TMCI vs LUNG

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 21, 2026

TMCI

69.5
AI Score
VS
TMCI Wins

LUNG

60.2
AI Score

Investment Advisor Scores

TMCI

70score
Recommendation
BUY

LUNG

60score
Recommendation
BUY

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric TMCI LUNG Winner
Revenue 92.57M 43.34M TMCI
Net Income -33.83M -23.73M LUNG
Gross Margin 78.9% 78.0% TMCI
Net Margin -36.5% -54.8% TMCI
Operating Income -32.13M -22.01M LUNG
ROE -49.9% -60.6% TMCI
ROA -18.7% -20.7% TMCI
Total Assets 181.06M 114.73M TMCI
Cash 12.61M 55.84M LUNG
Debt/Equity 0.83 0.96 TMCI
Current Ratio 2.90 4.32 LUNG
Free Cash Flow -2.72M -15.32M TMCI

Relative Price Performance (Last 90 Days)

TMCI 1M: -6.4% · 3M: +5.5% LUNG 1M: -7.5% · 3M: +58.1%

Current Technical Phase

TMCI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 50.0 · Price: $4.22

LUNG

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 48.0 · Price: $1.85

Fundamentals Snapshot

Metric TMCI LUNG
Market Cap — —
Forward P/E -4.9 -1.9
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin 0.8% 0.8%
Operating Margin -0.3% -0.4%
EPS -0.92 -1.15
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, TMCI is currently the stronger investment candidate, winning 8 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.